多发性-话题@MedSci

#多发性#

905篇内容 | 2933人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1889969, encodeId=ba7d18899693e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 ABN指南：妊娠期多发性硬化, objectType=article, longId=158079, objectId=b54b1580e906, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b54b1580e906, replyNumber=0, likeNumber=38, createdTime=2019-04-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54b1580e906, moduleTitle=2019 ABN指南：妊娠期多发性硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54b1580e906)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890059, encodeId=2317189005968, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性骨髓瘤治疗：Kyprolis与Darzalex的组合在III期试验中达到了主要终点, objectType=article, longId=179450, objectId=b45b1e9450d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b45b1e9450d9, replyNumber=0, likeNumber=0, createdTime=2020-03-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b45b1e9450d9, moduleTitle=多发性骨髓瘤治疗：Kyprolis与Darzalex的组合在III期试验中达到了主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b45b1e9450d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890025, encodeId=cd9718900254e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=遗传性多发性外生骨疣伴颈髓压迫1例, objectType=article, longId=170131, objectId=c5201e013124, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5201e013124, replyNumber=0, likeNumber=61, createdTime=2019-08-14, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5201e013124, moduleTitle=遗传性多发性外生骨疣伴颈髓压迫1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5201e013124)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889991, encodeId=11ef1889991ae, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=创造一个没有多发性骨髓瘤的未来国际骨髓瘤关爱月宣传拉开帷幕, objectType=article, longId=161653, objectId=3be21616534d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be21616534d, replyNumber=0, likeNumber=82, createdTime=2019-10-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be21616534d, moduleTitle=创造一个没有多发性骨髓瘤的未来国际骨髓瘤关爱月宣传拉开帷幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be21616534d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889946, encodeId=db3f18899461f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2018 MS学会建议：多发性硬化的认知筛查和管理, objectType=article, longId=151477, objectId=4ec91514e7b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ec91514e7b4, replyNumber=0, likeNumber=29, createdTime=2018-12-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ec91514e7b4, moduleTitle=2018 MS学会建议：多发性硬化的认知筛查和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ec91514e7b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889972, encodeId=6e3218899e2d6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NATURE：多发性硬化症中髓鞘的动态生成, objectType=article, longId=158942, objectId=fb99158942d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb99158942d3, replyNumber=0, likeNumber=91, createdTime=2019-05-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb99158942d3, moduleTitle=NATURE：多发性硬化症中髓鞘的动态生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb99158942d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889990, encodeId=1b6118899903b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 , objectType=article, longId=161249, objectId=55e816124925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55e816124925, replyNumber=0, likeNumber=69, createdTime=2019-10-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e816124925, moduleTitle=Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e816124925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890007, encodeId=7905189000e12, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, objectType=article, longId=166061, objectId=e9c816606197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9c816606197, replyNumber=0, likeNumber=70, createdTime=2019-12-28, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9c816606197, moduleTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9c816606197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889977, encodeId=852918899e78d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗, objectType=article, longId=159712, objectId=5b9d159e12a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9d159e12a2, replyNumber=0, likeNumber=100, createdTime=2019-10-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9d159e12a2, moduleTitle=Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9d159e12a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889947, encodeId=908b188994ecc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：Selinexor联合低剂量硼替佐米和地塞米松（SVd）用于复发性/难治性多发性骨髓瘤的疗效和安全性, objectType=article, longId=151955, objectId=4deb1519558a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4deb1519558a, replyNumber=0, likeNumber=60, createdTime=2018-12-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4deb1519558a, moduleTitle=Blood：Selinexor联合低剂量硼替佐米和地塞米松（SVd）用于复发性/难治性多发性骨髓瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4deb1519558a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890022, encodeId=b0a31890022dc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NEJM：口服BTK抑制剂治疗多发性硬化, objectType=article, longId=168870, objectId=9b371688e02f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b371688e02f, replyNumber=0, likeNumber=59, createdTime=2020-03-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b371688e02f, moduleTitle=NEJM：口服BTK抑制剂治疗多发性硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b371688e02f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889995, encodeId=aaf81889995df, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=外阴多发性浅表型基底细胞癌1 例, objectType=article, longId=162720, objectId=092f162e206b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=092f162e206b, replyNumber=0, likeNumber=36, createdTime=2019-05-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=092f162e206b, moduleTitle=外阴多发性浅表型基底细胞癌1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=092f162e206b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890018, encodeId=714a189001822, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=以来那度胺为基础的治疗方案在多发性骨髓瘤治疗中的优势, objectType=article, longId=168279, objectId=f51c1682e94f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f51c1682e94f, replyNumber=0, likeNumber=147, createdTime=2020-04-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f51c1682e94f, moduleTitle=以来那度胺为基础的治疗方案在多发性骨髓瘤治疗中的优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f51c1682e94f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889938, encodeId=413b188993874, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹, objectType=article, longId=148311, objectId=72c21483118d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72c21483118d, replyNumber=0, likeNumber=65, createdTime=2019-03-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72c21483118d, moduleTitle=Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72c21483118d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889962, encodeId=0b68188996219, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2018年ASH年会：Darzalex显著降低初治型多发性骨髓瘤患者的疾病进展风险和死亡率, objectType=article, longId=155285, objectId=2ea6155285c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ea6155285c7, replyNumber=0, likeNumber=89, createdTime=2019-10-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ea6155285c7, moduleTitle=2018年ASH年会：Darzalex显著降低初治型多发性骨髓瘤患者的疾病进展风险和死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ea6155285c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890032, encodeId=965c18900320a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019年欧洲神经病学学会EAN：Ozanimod显着减少复发多发性硬化患者的脑容量损失, objectType=article, longId=174978, objectId=38d91e49784e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38d91e49784e, replyNumber=0, likeNumber=107, createdTime=2020-05-11, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38d91e49784e, moduleTitle=2019年欧洲神经病学学会EAN：Ozanimod显着减少复发多发性硬化患者的脑容量损失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38d91e49784e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889959, encodeId=a61a1889959fc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NCCN临床实践指南：多发性骨髓瘤（2019.V2）, objectType=article, longId=154340, objectId=427e15434000, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=427e15434000, replyNumber=0, likeNumber=43, createdTime=2019-03-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=427e15434000, moduleTitle=NCCN临床实践指南：多发性骨髓瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=427e15434000)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889968, encodeId=58541889968fe, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性硬化诊断和治疗中国专家共识（2018版）, objectType=article, longId=157859, objectId=bb1415e8597b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb1415e8597b, replyNumber=0, likeNumber=33, createdTime=2019-03-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb1415e8597b, moduleTitle=多发性硬化诊断和治疗中国专家共识（2018版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb1415e8597b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889973, encodeId=4d2b18899e309, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=CLIN CANCER RES：Evofosfamide联合硼替佐米治疗复发/难治性多发性骨髓瘤, objectType=article, longId=159007, objectId=7dba15900edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dba15900edc, replyNumber=0, likeNumber=63, createdTime=2019-02-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dba15900edc, moduleTitle=CLIN CANCER RES：Evofosfamide联合硼替佐米治疗复发/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dba15900edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889979, encodeId=b07018899e90b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：多发性骨髓瘤影像学检查：Which? When?, objectType=article, longId=159867, objectId=d86715986ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d86715986ecf, replyNumber=0, likeNumber=70, createdTime=2019-06-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d86715986ecf, moduleTitle=Blood：多发性骨髓瘤影像学检查：Which? When?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d86715986ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 ABN指南：妊娠期多发性硬化

2019-04-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性骨髓瘤治疗：Kyprolis与Darzalex的组合在III期试验中达到了主要终点

2020-03-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

遗传性多发性外生骨疣伴颈髓压迫1例

2019-08-14

jml2009 (审核中...)

前往app查看评论内容

#多发性#

创造一个没有多发性骨髓瘤的未来国际骨髓瘤关爱月宣传拉开帷幕

2019-10-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2018 MS学会建议：多发性硬化的认知筛查和管理

2018-12-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NATURE：多发性硬化症中髓鞘的动态生成

2019-05-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Alkermes和Biogen宣布美国FDA接受了Diroximel富马酸盐治疗多发性硬化症的新药申请 

2019-10-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

显著改善认知能力，诺华公布多发性硬化症新药全新数据分析

2019-12-28

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：多发性骨髓瘤治疗迈入“精准”时代——分子生物学检测指导个体化治疗

2019-10-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：Selinexor联合低剂量硼替佐米和地塞米松（SVd）用于复发性/难治性多发性骨髓瘤的疗效和安全性

2018-12-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NEJM：口服BTK抑制剂治疗多发性硬化

2020-03-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

外阴多发性浅表型基底细胞癌1 例

2019-05-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

以来那度胺为基础的治疗方案在多发性骨髓瘤治疗中的优势

2020-04-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹

2019-03-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2018年ASH年会：Darzalex显著降低初治型多发性骨髓瘤患者的疾病进展风险和死亡率

2019-10-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019年欧洲神经病学学会EAN：Ozanimod显着减少复发多发性硬化患者的脑容量损失

2020-05-11

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NCCN临床实践指南：多发性骨髓瘤（2019.V2）

2019-03-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性硬化诊断和治疗中国专家共识（2018版）

2019-03-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

CLIN CANCER RES：Evofosfamide联合硼替佐米治疗复发/难治性多发性骨髓瘤

2019-02-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：多发性骨髓瘤影像学检查：Which? When?

2019-06-21

科室
- - 订阅+
  - 更多科室
工具
服务